Oncology Expertise Emerging Biotechs Need
Pioneering in the fight against cancer is marked by a range of challenges from disease heterogeneity, diversity of treatment, regulatory hurdles and fierce competition. These challenges can be compounded for emerging innovators who must achieve success with leaner teams, fewer resources and tighter timelines. PPD Biotech will help you overcome those challenges.
We are a global leader in oncology development, with seasoned operational and medical experts. Our experience spans a wide range of malignancies and treatment modalities, including breakthroughs in cell and gene therapies and immuno-oncology.
Move Your Research Forward
Our teams bring strength, experience and reach in oncology within a “small team” model.
Oncology and Hematology Studies
Advance Your Oncology Development With a True Partner
PPD Biotech serves emerging biotech companies with heightened responsiveness and flexibility. With a shared sense of urgency for advancing your therapy, our teams know that every milestone and change in direction is critically important.
Whether you are preparing for a small dose-finding study or a Phase III pivotal trial, we are here to navigate complexity with you and simplify your journey.
Hear from Our Experts
From dose escalation strategy to site engagement and market approval, finding the right CRO for your oncology trial can be a daunting but necessary step. Take a look at things to consider when choosing a CRO to help bring your oncology assets to market.
VAST RESOURCES AND EXPERTISE IN ONCOLOGY
With more than 2,100 hematology and oncology trained staff, you will have dedicated resources across your program, ready to scale up quickly as your therapy advances. PPD Biotech has the experience and the knowledge staff needed to deliver the right development strategy and operational excellence in oncology.
- Regulatory strategy
- Adaptive trial designs
- Doses escalation and safety risk management strategy
- Identification of patient pathways
- Sophisticated, data-driven country and site strategies
- Biomarker-driven randomization
- Evidence strategies
- Expertise in cell and gene therapy and immuno-oncology
- A full range of oncology and hematology labs solutions
A small biotech company contracted PPD Biotech to conduct a global Phase III trial for a metastatic breast cancer study that was facing recruitment challenges. See how we helped a single-asset biotech advance breast cancer enrollment.